Back to discover
Disease
Central Serous Chorioretinopathy
Late-stage therapeutic developmentEmerging research
1
Publications
13
Clinical trials
1
Associated genes
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2021-05-21Progress in retinal and eye research
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 4 industry developments reported.
Industry & MarketViewHide
- 2026-08-04Optical coherence tomography-guided focal navigated laser photocoagulation in central serous chorioretinopathy: a non-inferiority studyResearch news · American Journal of Ophthalmology
- 2026-08-24Central Serous Chorioretinopathy in patients with preexisting immune-mediated disorders: MICRoN report 21Industry · American Journal of Ophthalmology
- 2026-05-23Morphologic Staging of Photoreceptor Damage as a Predictor of Visual Recovery After PDT in Chronic Central Serous ChorioretinopathyIndustry · American Journal of Ophthalmology
- 2026-05-20Imaging Characteristics and Longitudinal Follow-Up of Inner Choroidal Fibrosis in Chronic Central Serous ChorioretinopathyIndustry · American Journal of Ophthalmology
Activity timeline4
- 2026-08-24IndustryCentral Serous Chorioretinopathy in patients with preexisting immune-mediated disorders: MICRoN report 21Industry · American Journal of Ophthalmology
- 2026-08-04IndustryOptical coherence tomography-guided focal navigated laser photocoagulation in central serous chorioretinopathy: a non-inferiority studyResearch news · American Journal of Ophthalmology
- 2026-05-23IndustryMorphologic Staging of Photoreceptor Damage as a Predictor of Visual Recovery After PDT in Chronic Central Serous ChorioretinopathyIndustry · American Journal of Ophthalmology
- 2026-05-20IndustryImaging Characteristics and Longitudinal Follow-Up of Inner Choroidal Fibrosis in Chronic Central Serous ChorioretinopathyIndustry · American Journal of Ophthalmology
Clinical trials
The current development programme across all trial phases.
Clinical programme
13
0
2
6
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes2
- Central Serous Chorioretinopathy1
- Choroid Diseases1
Leading journals1
- Progress in retinal and eye research1
Leading researchers8
- Behar-Cohen F1
- Boon CJF1
- Brown DM1
- Chhablani J1
- Gemmy Cheung CM1
- Hartnett ME1
- Iida T1
- Kishi S1
Affiliations (unnormalised)6
- Clinical Research Department1
- Gunma University Graduate School of Medicine1
- Institute of Molecular and Clinical Ophthalmology Basel1
- John A. Moran Eye Center1
- Leiden University Medical Center1
- Maebashi Central Eye Clinic1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.